Ironwood Pharmaceuticals Reports Second Quarter 2020 Results; Delivered GAAP Net Income of $25 Million and Adjusted EBITDA of $33 Million
Go back to Ironwood Pharmaceuticals Reports Second Quarter 2020 Results; Delivered GAAP Net Income of $25 Million and Adjusted EBITDA of $33 Million| IRONWOOD PHARMA-A (NASDAQ: IRWD) | Delayed: 4.41 +0.05 (1.15%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $4.36 | 52 Week High | $16.89 | |||
| Open | $4.39 | 52 Week Low | $7.35 | |||
| Day High | $4.60 | P/E | N/A | |||
| Day Low | $4.30 | EPS | $-2.35 | |||
| Volume | 2,414,951 | |||||
